Skip to main content
Article
Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use.
Meyers Primary Care Institute Publications and Presentations
  • Danny McCormick, University of Massachusetts Medical School
  • Jerry H. Gurwitz, University of Massachusetts Medical School
  • Robert J. Goldberg, University of Massachusetts Medical School
  • Jack E. Ansell, University of Massachusetts Medical School
UMMS Affiliation
Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine; Department of Medicine, Division of Cardiovascular Medicine
Date
4-1-1999
Document Type
Article
Medical Subject Headings
Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Drug Monitoring; Hemorrhage; Humans; Practice Guidelines as Topic; Prothrombin Time; Quality Assurance, Health Care; Risk Factors; Stroke
Rights and Permissions
Citation: J Thromb Thrombolysis. 1999 Apr;7(2):157-63.
Related Resources
Link to article in PubMed
PubMed ID
10364772
Citation Information
Danny McCormick, Jerry H. Gurwitz, Robert J. Goldberg and Jack E. Ansell. "Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use." Vol. 7 Iss. 2 (1999) ISSN: 0929-5305
Available at: http://works.bepress.com/robert_goldberg/37/